Search research articles
Contact Us
Filters
Showing results (1211-1220 of 1,909) with videos related to
Page
of 191
Sort By:
Gut
|
June 1, 1984
Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum
K J Moriarty, J E Hegarty, K Tatemoto, et al.
Nihon Naibunpi Gakkai Zasshi
|
February 20, 1982
[The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)]
C Nakanome, H Akai, M Umezu, et al.
Endocrinology
|
April 4, 2000
Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase
F Satoh, S A Beak, C J Small, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study
K Meeran, D O'Shea, P D Upton, et al.
Clinical Endocrinology
|
December 18, 2003
The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency
Iqbal A Malik, Patrick J English, Mohammed A Ghatei, et al.
Journal of Cardiovascular Pharmacology
|
July 1, 1992
Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans
J B Warren, J R Cockcroft, S W Larkin, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1980
The effect of pirenzepine on meal-stimulated gastrointestinal hormones
H N El-Sabbagh, S R Bloom, T E Adrian, et al.
Obesity (Silver Spring, Md.)
|
October 26, 2018
L-Arginine Increases Postprandial Circulating GLP-1 and PYY Levels in Humans
Anjali Amin, Christina Neophytou, Shermaine Thein, et al.
Diabetes
|
January 19, 1999
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39
C M Edwards, J F Todd, M Mahmoudi, et al.
International Journal of Obesity (2005)
|
April 19, 2006
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial
K Wynne, A J Park, C J Small, et al.
Page
of 191
Search research articles
Search
Showing results (1211-1220 of 1,909) with videos related to
Sort By:
Page
of 191
Gut
|
June 1, 1984
Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum
K J Moriarty, J E Hegarty, K Tatemoto, et al.
Nihon Naibunpi Gakkai Zasshi
|
February 20, 1982
[The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)]
C Nakanome, H Akai, M Umezu, et al.
Endocrinology
|
April 4, 2000
Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase
F Satoh, S A Beak, C J Small, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study
K Meeran, D O'Shea, P D Upton, et al.
Clinical Endocrinology
|
December 18, 2003
The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency
Iqbal A Malik, Patrick J English, Mohammed A Ghatei, et al.
Journal of Cardiovascular Pharmacology
|
July 1, 1992
Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans
J B Warren, J R Cockcroft, S W Larkin, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1980
The effect of pirenzepine on meal-stimulated gastrointestinal hormones
H N El-Sabbagh, S R Bloom, T E Adrian, et al.
Obesity (Silver Spring, Md.)
|
October 26, 2018
L-Arginine Increases Postprandial Circulating GLP-1 and PYY Levels in Humans
Anjali Amin, Christina Neophytou, Shermaine Thein, et al.
Diabetes
|
January 19, 1999
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39
C M Edwards, J F Todd, M Mahmoudi, et al.
International Journal of Obesity (2005)
|
April 19, 2006
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial
K Wynne, A J Park, C J Small, et al.
Page
of 191